NEWTON, Mass.--(BUSINESS WIRE)--Allena Pharmaceuticals, a specialty biopharmaceutical company focused on developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, announced today that Alexey Margolin, Ph.D., president and chief executive officer of Allena, will provide a corporate presentation at the 34th Annual J.P. Morgan Healthcare Conference at 11:30 a.m. PT (2:30 p.m. ET), on Thursday, January 14, 2016, in the Elizabethan D room at the Westin St. Francis Hotel in San Francisco.
